Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 11.6 M11.53 M10.92 M11.61 M15.3 M 49.37 M Research & development ————— — Operating income 15.32 M760 K12.68 M20.66 M158.51 M 192.61 M Non-Operating Income, Total 7.72 M6.3 M4.36 M5.24 M4.17 M 20.08 M Interest expense, net of interest capitalized 2.61 M2.56 M2.98 M2.29 M2.26 M 10.08 M Non-Operating Income, excl. Interest Expenses 5.11 M3.75 M1.39 M2.95 M1.91 M 9.99 M Unusual income/expense ————— — Pretax income -11.54 M-20.73 M-10.95 M3.63 M139.12 M 111.06 M Equity in earnings -1.71 M-4.19 M-3.69 M1.89 M-1.51 M -7.51 M Taxes 116 K211 K2 00083 K12 K 308 K Non-controlling/minority interest -11.6 M-21.18 M-15.01 M-3.56 M109.33 M 69.58 M After tax other income/expense 2.28 M2.97 M2.42 M431 K3.19 M 9.02 M Net income before discontinued operations -11.66 M-20.94 M-10.96 M3.54 M139.11 M 110.76 M Discontinued operations ————— — Net income -11.66 M-20.94 M-10.96 M3.54 M139.11 M 110.76 M Dilution adjustment —22.91 M17.46 M-40 K-106.84 M -66.52 M Preferred dividends —0888 K-4.2 M1.79 M -1.52 M Diluted net income available to common stockholders 1.61 M1.96 M5.62 M7.71 M30.48 M 45.77 M Basic earnings per share (Basic EPS) 0.010.010.030.050.22 0.31 Diluted earnings per share (Diluted EPS) 0.010.010.030.050.22 0.31 Average basic shares outstanding 121.33 M130.98 M131.02 M128.62 M131.25 M — Diluted shares outstanding 121.33 M130.98 M131.02 M128.66 M131.33 M — EBITDA -49.65 M-60.04 M-49.33 M-23.34 M56.52 M -76.18 M EBIT -89.09 M-99.31 M-88.21 M-63.2 M16.36 M -234.36 M Cost of revenue 18.4 M17.1 M16.61 M19 M18.79 M 71.5 M Other cost of goods sold 18.28 M17.52 M16.63 M19 M18.25 M 71.4 M Depreciation & amortization (cash flow) 39.44 M39.27 M38.88 M39.86 M40.16 M 158.17 M